Completed Ph 1/2 Study Evaluating Safety and Tolerability of Inhaled AP-PA02 in Subjects With Chronic Pseudomonas Aeruginosa Lung Infections and Cystic Fibrosis NCT04596319 Conditions Bacterial Infections, Bacterial Infections and Mycoses, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more Locations Children's Hospital Los Angeles — Los Angeles, California, United States University of South Florida — Tampa, Florida, United States St. Luke's Cystic Fibrosis Center of Idaho — Boise, Idaho, United States Northwestern University — Chicago, Illinois, United States View all 20 locations View more locations Show fewer locations Loading locations... View Trial Details
Completed Aztreonam for Inhalation Solution (AZLI) for the Treatment of Exacerbations of Cystic Fibrosis NCT02894684 Conditions Bacterial Infections, Bacterial Infections and Mycoses, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +12 more Locations Liverpool Heart & Chest Hospital NHS Trust — Liverpool, United Kingdom View Trial Details
